Charlotte, N.C.—For the past 20 years, prophylactic vena cava filters have been recommended to avoid venous thromboembolism in trauma patients who cannot receive anticoagulant drugs. But the use of these filters has come into question in recent years, and one study has added to a growing body of literature that indicates no benefit from this practice.
“We thought that the use of pVCF [prophylactic vena cava filters] would result in lower rates of pulmonary embolism